Pathological choroidal neovascularization (CNV) formation is a classic hallmark of wet age-related macular degeneration (AMD). In order to help customers around the world better understand and develop more effective treatments for wet ADM, Ace Therapeutics has created the most comprehensive and reliable choroidal neovascularization model platform. We are now proud to offer you a laser-induced minipig choroidal neovascularization model. Here, you will benefit from our advanced non-invasive fluorescein angiography imaging system, which ensures the model's reliability to a significant extent.
Fig. 1. Histopathology of type 2 choroidal neovascularization (CNV). (Tran J, et al., 2017)
Pigs are an excellent surrogate for large animal models of neovascular age-related macular degeneration due to their similar spheroid size and retinal anatomy to humans. As a full-service ophthalmology preclinical CRO, Ace Therapeutics has successfully developed a porcine choroidal neovascularization model.
This model is an ideal choice for characterizing novel research molecules for proliferative posterior segment diseases of the eye and can aid our customers in wet age-related macular degeneration research. Importantly, we can work with you at any stage of project development to expedite project timelines in all application areas.
Ace Therapeutics researchers use minipigs to build a laser-induced CNV model. Specifically, six lesions were created around the optic disc (OD) of minipigs using a 532nm green argon laser to create a minipig CNV model with a follow-up period of 15 days. This animal model was highly correlated with CNVs that occasionally occur in human eyes after accidental laser burns.
It is worth mentioning that our laser conditions were determined by trial and error by our scientists to induce uniform, consistent subretinal plaques and observed subretinal fibrosis in minipigs.
Model characteristics: Lesions producing marked rupture of Bruch's membrane, edema, and neovascularization with subretinal fibrosis with mild exudate and hyperemia.
To verify the high reliability of the model, Ace Therapeutics researchers develop a series of non-invasive fluorescein angiography imaging systems for visualization and quantitative assessment of leakage and lesion size, including:
Ace Therapeutics is committed to being your trusted partner in eye disease research. We provide an unparalleled miniature porcine choroidal neovascularization model to our global customers. If you are interested in our services or need more detailed information, please feel free to contact us. Our experienced scientists are ready to help you!
References